GlassScriptPhysician profile
Michelle Y Hardaway
NPI 1396883484
$1,734.97
in general payments reported to CMS, 2019-2025
10 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $18.24 · 2021: $133 · 2022: $63.87 · 2023: $105 · 2024: $849 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,199 · Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,198.87 |
| Food and Beverage | $178.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,248.45 | 2024-2025 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Mentor Worldwide LLC | $143.97 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $78.38 | 2019-2021 | |
| Galderma Laboratories, L.P. | $77.32 | 2019-2021 | |
| Sientra, INC. | $61.67 | 2021-2022 | |
| Abbvie INC. | $46.21 | 2023-2024 | |
| Solta Medical, A Division of Bausch Health US, LLC | $23.73 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $23.23 | 2021 | |
| Ethicon US, LLC | $21.20 | 2022 | |
| Tepha INC | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Hardaway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.